ANZ News
It follows the clearance for connecting Hailie with AstraZeneca's Symbicort inhaler.
It has also entered into a collaboration with The Pharmacy Guild of Australia for health service initiatives.
The VR app has been shown to reduce 75% of phobia symptoms after six weeks of treatment.
Also, annalise.ai has made key executive appointments to support its global expansion.
It has been approved as a prescription-only software-as-a-medical device in the US.
The company has received backing from the state government of Western Australia.
Also, I-MED will expand its deployment of 4DMedical's lung imaging tool across its network in Australia.
It has zoom, rotate, and annotate features to help specialists explain procedures to patients virtually.
The company has also launched a distribution unit in the United States.
Two variants of the Annalise CXR Edge products will be offered in Australia.